Keyphrases
PET Scan
100%
18F-FDG PET-CT
100%
Lung Cancer
100%
Patient Management
100%
Recurrence or Metastasis
37%
Clinical Assessment
37%
Medicare
25%
Clinical Suspicion
25%
Treatment Change
25%
FDG-PET Scan
25%
Clinical Treatment
12%
Tertiary Care Hospital
12%
Tumor Subtype
12%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Clinical Impact
12%
Institutional Review Board
12%
Biopsy-proven
12%
Medicaid
12%
Administrators
12%
Impact on Patients
12%
Assessment Change
12%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Lung Cancer
100%
Patient Care
100%
Fluorodeoxyglucose F 18
100%
Metastatic Carcinoma
23%
Recurrent Disease
23%
Clinical Assessment
23%
Medicare
15%
Neoplasm
7%
Biopsy
7%
Retrospective Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Fluorodeoxyglucose F 18
100%
Recurrent Disease
75%
Neoplasm
25%
Retrospective Study
25%
Neuroscience
Positron Emission Tomography-Computed Tomography
100%
Fluorine-18
100%
Clinical Assessment
23%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
76%